Gadde KM, Vetter ML, Iqbal N, Hardy E, Öhman P; DURATION-NEO-2 study investigators. Efficacy and safety of auto injected exenatide once-weekly suspension versus sitagliptin or placebo with metformin in patients with type 2 diabetes: The DURATION-NEO-2 randomized clinical study.
Diabetes Obes Metab. 2017;19:979–988.
Tauber J, Karpecki P, Latkany R, Luchs J, Martel J, Sall K, Raychaudhuri A, Smith V, Semba CP; OPUS-2 Investigators. Lifitegrast ophthalmic solution 5.0% versus placebo for treatment of dry eye disease: results of the randomized phase III OPUS-2 study.
Salles MJ, Zurita J, Mejía C, Villegas MV; Latin America Working Group on Bacterial Resistance. Resistant gram-negative infections in the outpatient setting in Latin America.
Epidemiol Infect. 2013;141:2459–2472.
Dahlin LB, Bainbridge C, Szczypa PP, Cappelleri JC, Guérin D, Gerber RA. Current trends in the surgical management of Dupuytren’s disease in Europe: the surgeon’s perspective. Eur Orthop Traumatol. 2012;3:25–30.
Presented at: The American Diabetes Association’s 76th Scientific Sessions (ADA 2016); June 10–14, 2016; New Orleans, LA.
Presented at: The 21st European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) / 27th International Congress of Chemotherapy (ICC) Congress; May 7-10, 2011; Milan, Italy.
Promotional Poster, Antifungal, 2006.
Presented at: The American Academy of Optometry (AAO) 2015 Annual Meeting; October 7–10, 2015; New Orleans, LA.
Presented at: The European Federation of National Associations of Orthopaedics and Traumatology (EFORT) Congress; June 1–4, 2011; Copenhagen, Denmark.
CME Slide Deck, Multidrug-Resistant Infections, 2010.
Promotional Slide Deck, Antibiotic, 2008.
Not Included Here for Confidentiality Reasons
- Scientific communication platforms
- Gap analyses
- Literature assessments
- Tactical publication plans
- Advisory board executive summaries
- MSL training materials
- Sales force training materials
- CME grant proposals